Dialysis Solution

WASHINGTON — Data presented at ASN Kidney Week show Outset Medical’s Tablo hemodialysis system was safe and effective for both in-center or at-home use.

An 11-year development cycle with an artificial kidney device using an approach similar to PD therapy has been successful in Japan, according to a speaker here.

Rockwell Medical Inc. announced the FDA has recently accepted the company’s new drug application for its IV formulation of Triferic with a Prescription Drug User Fee Act date set for March 28, 2020.